Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01052532 · ClinicalTrials.gov registry record
Molecular Mechanisms of Mitral Regurgitation-Aim 2
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 65
- Enrollment target
NCT01052532 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 65 participants.
The verdict
NCT01052532 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
The investigators hypothesize that MR in humans is characterized by adrenergic overdrive, reactive nitrogen species, and an antifibrotic phenotype that relate to the severity of adverse LV remodeling prior to surgery and outcome after valve repair.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2005-06 |
| Est. Completion | 2010-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01052532
The ClinicalTrials.gov registry entry for NCT01052532 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01052532 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01052532 about?
NCT01052532 is a clinical study titled "Molecular Mechanisms of Mitral Regurgitation-Aim 2". The investigators hypothesize that MR in humans is characterized by adrenergic overdrive, reactive nitrogen species, and an antifibrotic phenotype that relate to the severity of adverse LV remodeling prior to surgery and outcome after valve repair.
What is the current status of trial NCT01052532?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2005-06. Estimated completion is 2010-11.
Who is sponsoring clinical trial NCT01052532?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.